Compass Therapeutics

CMPX

Capitalización de mercado USD 138 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 OrbiMed New York	USD 50.1 M	–	–	–
2	2 Fidelity Investments Boston, Massachusetts	USD 14.5 M	-USD 1.43 M	-517,600	-8%
3	3 Rock Springs Capital Management Baltimore, Maryland	USD 12.2 M	+USD 14.1 k	+5,100	+0.1%
4	4 Adage Capital Partners Boston, Massachusetts	USD 10.5 M	+USD 554 k	+200,000	+5%
5	5 Foresite Capital Management V Larkspur, California	USD 10 M	–	–	–
6	6 Janus Henderson Group London,	USD 8.07 M	+USD 487 k	+175,809	+5%
7	7 CHI Advisors New York	USD 6.45 M	–	–	–
8	8 Vanguard Group Malvern, Pennsylvania	USD 5.43 M	+USD 2.43 M	+878,650	+58%
9	9 Avidity Partners Management Dallas, Texas	USD 4.56 M	–	–	–
10	10 Vivo Capital Palo Alto, California	USD 4.56 M	–	–	–
11	11 Foresite Capital Opportunity Management V Larkspur, California	USD 3.54 M	–	–	–
12	12 Blackstone Inc New York	USD 3.43 M	–	–	–
13	13 Monashee Investment Management Boston, Massachusetts	USD 2.8 M	–	–	–
14	14 Eventide Asset Management Boston, Massachusetts	USD 2.51 M	+USD 3.05 M	+1,100,399	Nuevas
15	15 BlackRock New York	USD 1.99 M	+USD 1.96 M	+709,071	+434%
16	16 Fred Alger Management New York	USD 1.39 M	–	–	–
17	17 Geode Capital Management Boston, Massachusetts	USD 1.37 M	+USD 1.6 M	+576,467	+2,319%
18	18 Silverarc Capital Management Boston, Massachusetts	USD 598 k	+USD 726 k	+262,090	Nuevas
19	19 DAFNA Capital Management Los Angeles, California	USD 429 k	-USD 27.7 k	-10,000	-5%
20	20 LMR Partners London, United Kingdom	USD 228 k	–	–	–
21	21 Northern Trust Chicago, Illinois	USD 199 k	+USD 242 k	+87,367	Nuevas
22	22 Renaissance Technologies New York	USD 146 k	-USD 5.4 k	-1,950	-3%
23	23 Millennium Management New York	USD 144 k	+USD 97.8 k	+35,326	+127%
24	24 Marshall Wace London, United Kingdom	USD 117 k	+USD 77.8 k	+28,089	+118%
25	25 Charles Schwab San Francisco, California	USD 73 k	+USD 87.9 k	+31,736	Nuevas

Compass Therapeutics CMPX Capitalización de mercado USD 138 M

Compass Therapeutics

CMPX

Capitalización de mercado USD 138 M